Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.3%

10 terminated/withdrawn out of 81 trials

Success Rate

86.1%

-0.4% vs industry average

Late-Stage Pipeline

7%

6 trials in Phase 3/4

Results Transparency

42%

26 of 62 completed trials have results

Key Signals

2 recruiting26 with results5 withdrawn

Enrollment Performance

Analytics

N/A
47(77.0%)
Phase 2
7(11.5%)
Phase 4
6(9.8%)
Phase 1
1(1.6%)
61Total
N/A(47)
Phase 2(7)
Phase 4(6)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (81)

Showing 20 of 81 trials
NCT05626491Not ApplicableActive Not Recruiting

Electrical Stimulation for the Treatment of Glaucoma

Role: collaborator

NCT04639635Suspended

CNGB1 and Allied Disorders

Role: collaborator

NCT01425944Active Not Recruiting

Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome

Role: collaborator

NCT04784234Not ApplicableTerminated

Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin

Role: lead

NCT05325996Not ApplicableCompleted

Evaluating Home Testing Devices for the Management of Glaucoma

Role: lead

NCT03675412Not ApplicableRecruiting

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

Role: lead

NCT00286637Recruiting

Novel Glaucoma Diagnostics

Role: lead

NCT05660447Phase 2Active Not Recruiting

A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR

Role: lead

NCT06130384Phase 4Completed

Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.

Role: lead

NCT02982629Not ApplicableCompleted

Improving Access to Eye Care in Glaucoma Patients

Role: lead

NCT02347670Not ApplicableCompleted

Comparison Study of Glaucoma Eye Care Follow-Up Adherence in a High Risk Population

Role: lead

NCT02390245Not ApplicableCompleted

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

Role: lead

NCT03804684Not ApplicableCompleted

visuALL Field Analyzer (vFA) Compared to Standard Humphrey Automated Perimetry

Role: lead

NCT03584958Unknown

Comparing Refractive and Visual Outcomes of MIGS and Traditional Surgeries

Role: lead

NCT04202510Not ApplicableWithdrawn

IOP and Medication Reduction in MIGS Procedures

Role: lead

NCT03323164Phase 4Completed

Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study

Role: lead

NCT04459949Not ApplicableUnknown

Comparative Study of Sharkskin Versus Grieshaber Forceps During ILM Peeling

Role: lead

NCT03034772Phase 2Completed

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

Role: lead

NCT02495935Not ApplicableUnknown

Transcorneal Electrical Stimulation (TES) for the Treatment of Amblyopia

Role: lead

NCT03365778Not ApplicableCompleted

Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment

Role: lead